The BioTech Pharma Summit: Liquid Biopsy 2018 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.
Pharmaceutical Lyophilisation 2018 will aim to keep attendees at the forefront of technological breakthroughs to adapt to growing manufacturing demands and cover key principles such as biological formulations, aseptic spray drying, scale up, cost, PAT and QbD.
A stage for the world’s leading experts in biorepositories, policy makers, and scientific actors to meet, in order to strengthen knowledge in biobanking as well as explore future advances in the field of biosampling for precision medicine, drug development and health research.
HPAPI 2018 will bring together perspectives from every stage of the drug development value chain – from bench to point of outsource – providing you with a unified outlook on the latest developments in highly potent manufacturing.
In the era of precision medicine, enormous amounts of data are being generated from disparate sources, including omics, imaging, sensing and beyond. Today, computational scientists need to develop better tools to manage, integrate and share data to make it clinically actionable.
On 29 & 30 October 2018, New York (USA) will host the BioTech Pharma Summit: Inhalation & Respiratory Drug Delivery 2018 conference. This year’s event is designed for senior industry experts that will showcase new trends in aerosol science and the future directions of inhalation drug delivery research. Further discussion focusses on the regulatory pathways for inhaled therapies...
NGS & Biostatistics 2018 will focus on the technology and it’s application to healthcare, the congress is designed to help you discover how your peers are using different technologies, the challenges they face and the solutions they have developed to overcome them.
The aim of the BioTech Pharma Summit: Bioprocessing & Cell Culture 2018 is is to assess the risks and benefits of the cell culture and cell therapy bio-manufacturing by focusing in particular on the feasibility of process automation: its impact on regulatory compliance and return on investment.
Immunotherapy 2018 helps to address the gaps in knowledge of how and when to combine therapies, and how to integrate immunotherapy into current standard-of-care or novel targeted therapy approaches – both preclinical and clinical,